Scriver et al., 1963 - Google Patents
The vitamin B6 deficiency syndrome in human infancy: biochemical and clinical observationsScriver et al., 1963
- Document ID
- 3845596060959103581
- Author
- Scriver C
- Hutchison J
- Publication year
- Publication venue
- Pediatrics
External Links
Snippet
A 14-month-old female infant with seizures, controlled by vitamin B6, was studied. Clinical and biochemical disturbances could be induced or corrected by manipulation of vitamin B6 intake. Seizures, hyperirritability, hyperacousis, and changes in growth rate comprised the …
- 201000007609 pyridoxine deficiency anemia 0 title description 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scriver et al. | The vitamin B6 deficiency syndrome in human infancy: biochemical and clinical observations | |
Kaufman et al. | Phenylketonuria due to a deficiency of dihydropteridine reductase | |
Perry et al. | Nonketotic hyperglycinemia: Glycine accumulation due to absence of glycine cleavage in brain | |
Kopple et al. | Daily requirement for pyridoxine supplements in chronic renal failure | |
Lumeng et al. | Vitamin B 6 Metabolism in Chronic Alcohol Abuse: Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes | |
Lonsdale | A review of the biochemistry, metabolism and clinical benefits of thiamin (e) and its derivatives | |
Inoue et al. | Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives | |
Krause et al. | Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. | |
Heird et al. | Metabolic acidosis resulting from intravenous alimentation mixtures containing synthetic amino acids | |
Blass et al. | An inherited defect affecting the tricarboxylic acid cycle in a patient with congenital lactic acidosis | |
Rivlin | Riboflavin metabolism | |
Hiratsuka et al. | Supplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects | |
Forslund et al. | Inverse relationship between protein intake and plasma free amino acids in healthy men at physical exercise | |
Clow et al. | Outcome of early and long-term management of classical maple syrup urine disease | |
Carson et al. | Treatment of homocystinuria with pyridoxine. A preliminary study. | |
Frimpter et al. | Vitamin B6-dependency syndromes: new horizons in nutrition | |
Wadlington et al. | Hyperglycinemia and propionyl CoA carboxylase deficiency and episodic severe illness without consistent ketosis | |
INGEBORG et al. | Atypical Clinical Course of Ornithine Transcarbamyiase Deficiency Due to a New Mutant (Comparison with Reye's Disease) | |
Ozalp et al. | Plasma amino acid response in young men given diets devoid of single essential amino acids | |
Narisawa et al. | Dihydropteridine reductase deficiency: diagnosis by leukocyte enzyme assay | |
Efron et al. | The aminoacidurias | |
Mydlik et al. | Vitamins and continuous ambulatory peritoneal dialysis (CAPD) | |
Bachmann | Inherited hyperammonemias | |
Regula Baumgartner et al. | Comparison of folic acid coenzyme distribution patterns in patients with methylenetetrahydrofolate reductase and methionine synthetase deficiencies | |
Borden et al. | Hawkinsinuria in two families |